A 35-year-old patient is diagnosed with severe Major Depressive Disorder without psychotic features. Arrange the following interventions in the standard sequential order of a stepped-care approach for this patient, progressing from the initial evaluation and management to interventions for highly treatment-resistant disease. Assume an inadequate clinical response to each preceding step.
- 1Screen for a history of hypomania or mania, then initiate monotherapy with a first-line antidepressant such as a selective serotonin reuptake inhibitor (SSRI).
- 2Optimize the dosage of the initial medication to the maximum tolerated dose or switch to a different first-line monotherapy.
- 3Augment the current regimen with a medication of a different class, such as a second-generation antipsychotic or lithium.
- 4Initiate a neuromodulation therapy, such as electroconvulsive therapy (ECT).
Answer
The correct sequence begins with screening for bipolar disorder and initiating first-line monotherapy, followed by optimizing or switching that monotherapy, then advancing to augmentation strategies, and finally utilizing electroconvulsive therapy for refractory cases.
The standard stepped-care algorithm for major depressive disorder begins with screening for bipolar disorder and starting a single first-line agent. If the response is inadequate, the dose is optimized or the patient is switched to another monotherapy. If monotherapy trials fail, an augmenting agent is added. Finally, if the patient is refractory to multiple pharmacological interventions, neuromodulation like ECT is utilized.
Step-by-Step Solution
Key Concept
The stepped-care pharmacological management of major depressive disorder progresses sequentially from monotherapy to augmentation, and ultimately to neuromodulation for severe treatment resistance.